The only roles for echo in selecting CRT are to assess LV ejection fraction and lateral wall function/ viability. No trials have shown any benefit or agreement in echo guidance of CRT parameters.
Echo is the cheepest tool to assess EF%. and without knowing that the EF150msec) and then you jump for Cardiac MRI for furture evaluation of (TM myocardial Scar + CS anatomy + Dyssynchrony ?
Until last week I would have stated in narrow complex and right bundle branch block patients, but with the presentation of ECHO-AF we need to question even this. It comes down to whether CRT as performed today is a treatment for complex Dyssynchrony ( by whatever definition) or for late activation of the lateral wall associated with LBBB. It now looks as if this is the answer until delivery systems can become more anatomically targeted.